Flexeril and Gabitril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Gabitril (tiagabine hydrochloride). Common drug interactions include nervousness among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Gabitril. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Gabitril?

Gabitril has active ingredients of tiagabine hydrochloride. It is often used in epilepsy. eHealthMe is studying from 2,230 Gabitril users. Check the latest studies of Gabitril.



On Jul, 26, 2026

40 people who take Flexeril and Gabitril together, and have interactions are studied.

Flexeril and Gabitril drug interactions.

What are the common drug interactions of Flexeril and Gabitril, by gender? *:

female:

  1. Nervousness
  2. Renal injury (kidney injury)
  3. Spinal disorder (disease of spine a back bone)
  4. Tinnitus (a ringing in the ears)
  5. Type 2 diabetes mellitus
  6. Violence-related symptom
  7. Abdominal pain upper
  8. Activities of daily living impaired
  9. Acute psychosis (period of mentally unstable behaviour)
  10. Ageusia (loss of taste functions of the tongue)

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Hyperglycaemia (high blood sugar)
  4. Memory impairment
  5. Panic attack
  6. Renal disorder (kidney disease)
  7. Tooth extraction
  8. Visual acuity reduced (reduced clearness of vision)
  9. Cough
  10. Dry mouth

What are the common drug interactions of Flexeril and Gabitril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Device failure
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hypertension (high blood pressure)
  5. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Hyperglycaemia (high blood sugar)
  3. Blood pressure decreased
  4. Blood pressure increased
  5. Candidiasis (candidiasis or thrush is a fungal infection)
  6. Chest pain
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Dizziness
  9. Dysuria (painful or difficult urination)
  10. Hypoaesthesia (reduced sense of touch or sensation)

40-49:

  1. Hyperlipidaemia (presence of excess lipids in the blood)
  2. Hypertension (high blood pressure)
  3. Hypoacusis (loss of hearing)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Incoherent (talking in a confused and unclear way)
  7. Inflammation
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Joint sprain (an injury to joint surrounding flexible fibres)
  10. Loss of consciousness

50-59:

  1. Swelling
  2. Activities of daily living impaired
  3. Acute psychosis (period of mentally unstable behaviour)
  4. Ageusia (loss of taste functions of the tongue)
  5. Aggression
  6. Anger
  7. Blepharospasm (any abnormal contraction or twitch of the eyelid)
  8. Blood pressure increased
  9. Chronic kidney disease
  10. Confusional state

60+:

  1. Cough
  2. Dry mouth
  3. Loss of consciousness
  4. Swelling
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Type 2 diabetes mellitus
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Fatigue (feeling of tiredness)
  9. Agitation (state of anxiety or nervous excitement)
  10. Delirium (wild excitement)

What are the existing conditions these people have? *

  1. Pain: 10 people, 25.00%
  2. Sleep Disorder: 5 people, 12.50%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.00%
  4. Depression: 4 people, 10.00%
  5. Stress And Anxiety: 3 people, 7.50%
  6. Muscle Rigidity (muscle stiffness): 3 people, 7.50%
  7. Joint Pain: 3 people, 7.50%
  8. High Blood Pressure: 3 people, 7.50%
  9. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 5.00%
  10. Oesophageal Candidiasis (fungal infection of oesophagus): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Gabitril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Gabitril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gabitril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabitril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and tiagabine hydrochloride (the active ingredients of Flexeril and Gabitril, respectively), and Flexeril and Gabitril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: